Ildikó Miklya

430 total citations
26 papers, 350 citations indexed

About

Ildikó Miklya is a scholar working on Cellular and Molecular Neuroscience, Molecular Biology and Pharmacology. According to data from OpenAlex, Ildikó Miklya has authored 26 papers receiving a total of 350 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Cellular and Molecular Neuroscience, 7 papers in Molecular Biology and 5 papers in Pharmacology. Recurrent topics in Ildikó Miklya's work include Neuroscience and Neuropharmacology Research (14 papers), Neurotransmitter Receptor Influence on Behavior (12 papers) and Parkinson's Disease Mechanisms and Treatments (4 papers). Ildikó Miklya is often cited by papers focused on Neuroscience and Neuropharmacology Research (14 papers), Neurotransmitter Receptor Influence on Behavior (12 papers) and Parkinson's Disease Mechanisms and Treatments (4 papers). Ildikó Miklya collaborates with scholars based in Hungary, Austria and Italy. Ildikó Miklya's co-authors include J. Knoll, B Knoll, Seiichiro Shimazu, Fumio Yoneda, K. Kelemen, P. Gaszner, László G. Hársing, Júlia Tímár, László Köles and Tamás Tábi and has published in prestigious journals such as International Journal of Molecular Sciences, British Journal of Pharmacology and Life Sciences.

In The Last Decade

Ildikó Miklya

22 papers receiving 326 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ildikó Miklya Hungary 10 204 106 72 65 36 26 350
Seiichiro Shimazu Japan 15 240 1.2× 157 1.5× 103 1.4× 68 1.0× 56 1.6× 25 448
Katarzyna Kamińska Poland 19 343 1.7× 188 1.8× 54 0.8× 79 1.2× 33 0.9× 30 589
Erin M. MacKenzie Canada 12 108 0.5× 122 1.2× 54 0.8× 90 1.4× 51 1.4× 26 411
Anna Dziubina Poland 16 297 1.5× 188 1.8× 93 1.3× 86 1.3× 50 1.4× 31 567
B Knoll Hungary 10 253 1.2× 104 1.0× 127 1.8× 96 1.5× 26 0.7× 33 441
M. Amin Khan United States 13 185 0.9× 205 1.9× 44 0.6× 149 2.3× 33 0.9× 16 579
Turgay Çelik Türkiye 14 254 1.2× 154 1.5× 56 0.8× 48 0.7× 12 0.3× 25 482
Fathi M. Sherif Libya 14 253 1.2× 92 0.9× 26 0.4× 53 0.8× 14 0.4× 45 489
Evelyn A. Williams United States 8 236 1.2× 103 1.0× 128 1.8× 52 0.8× 8 0.2× 12 408
Kazue Takahata Japan 13 122 0.6× 122 1.2× 78 1.1× 59 0.9× 29 0.8× 20 350

Countries citing papers authored by Ildikó Miklya

Since Specialization
Citations

This map shows the geographic impact of Ildikó Miklya's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ildikó Miklya with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ildikó Miklya more than expected).

Fields of papers citing papers by Ildikó Miklya

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ildikó Miklya. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ildikó Miklya. The network helps show where Ildikó Miklya may publish in the future.

Co-authorship network of co-authors of Ildikó Miklya

This figure shows the co-authorship network connecting the top 25 collaborators of Ildikó Miklya. A scholar is included among the top collaborators of Ildikó Miklya based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ildikó Miklya. Ildikó Miklya is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Al‐Khrasani, Mahmoud, Imre Boldizsár, Kornél Király, et al.. (2025). Do vitamins halt the COVID-19-evoked pro-inflammatory cytokines involved in the development of neuropathic pain?. Biomedicine & Pharmacotherapy. 189. 118346–118346. 1 indexed citations
2.
Zsilla, G., Ildikó Miklya, Júlia Tímár, et al.. (2025). Protective Effect of Selegiline (R-deprenyl) in Aminoglycoside-Induced Hearing Loss. Neurochemical Research. 50(3). 200–200.
3.
4.
5.
Hársing, László G., Júlia Tímár, & Ildikó Miklya. (2023). Striking Neurochemical and Behavioral Differences in the Mode of Action of Selegiline and Rasagiline. International Journal of Molecular Sciences. 24(17). 13334–13334. 3 indexed citations
6.
Hársing, László G., J. Knoll, & Ildikó Miklya. (2022). Enhancer Regulation of Dopaminergic Neurochemical Transmission in the Striatum. International Journal of Molecular Sciences. 23(15). 8543–8543. 8 indexed citations
7.
Miklya, Ildikó, Júlia Tímár, Tamás Tábi, et al.. (2021). Chronic Oral Selegiline Treatment Mitigates Age-Related Hearing Loss in BALB/c Mice. International Journal of Molecular Sciences. 22(6). 2853–2853. 7 indexed citations
8.
Knoll, J., et al.. (2019). Synthetic enhancer compounds, besides acting on biogenic amine system, influence the glutamate transmission and stress response. Behavioural Brain Research. 378. 112290–112290. 4 indexed citations
9.
Miklya, Ildikó. (2014). Essential difference between the pharmacological spectrum of (−)-deprenyl and rasagiline. Pharmacological Reports. 66(3). 453–458. 8 indexed citations
10.
Gaszner, P. & Ildikó Miklya. (2005). Major depression and the synthetic enhancer substances, (−)-deprenyl and R-(−)-1-(benzofuran-2-yl)-2-propylaminopentane. Progress in Neuro-Psychopharmacology and Biological Psychiatry. 30(1). 5–14. 11 indexed citations
11.
Gaszner, P. & Ildikó Miklya. (2004). The use of the synthetic enhancer substances (-)-deprenyl and (-)-BPAP in major depression.. PubMed. 6(4). 210–20. 2 indexed citations
12.
Shimazu, Seiichiro & Ildikó Miklya. (2004). Pharmacological studies with endogenous enhancer substances: β-phenylethylamine, tryptamine, and their synthetic derivatives. Progress in Neuro-Psychopharmacology and Biological Psychiatry. 28(3). 421–427. 43 indexed citations
13.
Knoll, J., Ildikó Miklya, & B Knoll. (2002). Stimulation of the catecholaminergic and serotoninergic neurons in the rat brain by R-(−)-1-(benzofuran-2-yl)-2-propylaminopentane, (−)-BPAP. Life Sciences. 71(18). 2137–2144. 13 indexed citations
14.
15.
16.
17.
Knoll, J., et al.. (1996). Phenylethylamine and tyramine are mixed-acting sympathomimetic amines in the brain. Life Sciences. 58(23). 2101–2114. 46 indexed citations
18.
19.
Knoll, J., B Knoll, & Ildikó Miklya. (1996). High performing rats are more sensitive toward catecholaminergic activity enhancer (CAE) compounds than their low performing peers. Life Sciences. 58(11). 945–952. 13 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Seiichiro Shimazu Breakdown of academic impact, for papers by Katarzyna Kamińska Breakdown of academic impact, for papers by Erin M. MacKenzie Breakdown of academic impact, for papers by Anna Dziubina Breakdown of academic impact, for papers by B Knoll Breakdown of academic impact, for papers by M. Amin Khan Breakdown of academic impact, for papers by Turgay Çelik Breakdown of academic impact, for papers by Fathi M. Sherif Breakdown of academic impact, for papers by Evelyn A. Williams Breakdown of academic impact, for papers by Kazue Takahata
Rankless by CCL
2026